Iqvia Holdings Inc (N:IQV)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for IQV within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET January 17th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jan 14/20 Jan 10/20 Evanisko Michael J Indirect Ownership Employee Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -6,250  
Jan 14/20 Jan 10/20 Evanisko Michael J Indirect Ownership Common Stock S - Open market or private sale -6,250 $160.08
Jan 14/20 Jan 10/20 Evanisko Michael J Indirect Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 6,250 $18.40
Jan 6/20 Jan 2/20 Mcdonnell Michael R Direct Ownership Common Stock S - Open market or private sale -12,000 $155.07
Jan 3/20 Dec 31/19 Bousbib Ari Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -86,874 $154.51
Dec 26/19 Dec 20/19 Leonard John M. Direct Ownership Employee Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -7,000  
Dec 26/19 Dec 20/19 Leonard John M. Direct Ownership Employee Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -6,600  
Dec 26/19 Dec 20/19 Leonard John M. Direct Ownership Employee Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -6,600  
Dec 26/19 Dec 20/19 Leonard John M. Direct Ownership Common Stock S - Open market or private sale -10,100 $155.00
Dec 26/19 Dec 20/19 Leonard John M. Direct Ownership Common Stock S - Open market or private sale -10,100 $151.00
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for IQV within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET January 17th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jan 14/20 Jan 10/20 Evanisko Michael J Indirect Ownership Employee Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -6,250  
Jan 14/20 Jan 10/20 Evanisko Michael J Indirect Ownership Common Stock S - Open market or private sale -6,250 $160.08
Jan 14/20 Jan 10/20 Evanisko Michael J Indirect Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 6,250 $18.40
Jan 6/20 Jan 2/20 Mcdonnell Michael R Direct Ownership Common Stock S - Open market or private sale -12,000 $155.07
Jan 3/20 Dec 31/19 Bousbib Ari Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -86,874 $154.51
Dec 26/19 Dec 20/19 Leonard John M. Direct Ownership Employee Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -7,000  
Dec 26/19 Dec 20/19 Leonard John M. Direct Ownership Employee Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -6,600  
Dec 26/19 Dec 20/19 Leonard John M. Direct Ownership Employee Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -6,600  
Dec 26/19 Dec 20/19 Leonard John M. Direct Ownership Common Stock S - Open market or private sale -10,100 $155.00
Dec 26/19 Dec 20/19 Leonard John M. Direct Ownership Common Stock S - Open market or private sale -10,100 $151.00
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $IQV

Competitors

Competitors with Recent Insider Filings
Vir Biotechnology (OQ:VIR)
Seattle Genetics (OQ:SGEN)
ACADIA Pharmaceuticals (OQ:ACAD)